USFDA concludes audit at Radiopharmaceutical manufacturing facility of Jubilant Pharmova’s arm

25 Apr 2024 Evaluate

United States Food and Drug Administration (USFDA) has concluded its audit at Jubilant Pharmova’s step down subsidiary -- Jubilant Draximage Inc’s Radiopharmaceutical manufacturing facility located at Montreal, Canada on April, 23, 2024. The USFDA has issued 5 observations pursuant to the completion of audit. The company will submit an action plan on the observations.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

902.15 5.80 (0.65%)
30-Apr-2025 15:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.00
Dr. Reddys Lab 1183.75
Cipla 1551.00
Lupin 2101.60
Zydus Lifesciences 889.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...